September 17 (SeeNews) - The shares of Bulgarian drug maker Unipharm [BUL:59X] were delisted from the Bulgarian Stock Exchange on Monday, after the documents regarding its merger into Sopharma were entered into the commercial register on September 13, the bourse operator said.
Unipharm shares have been suspended from trading on the BSE since August 2, when the company's shareholders approved an agreement with local peer Sopharma [BUL:3JR], under which Sopharma will absorb the company. Each Unipharm share will be converted into 0.957502 Sopharma shares, according to the agreement.
You can subscribe to our M&A newsletter here
Unipharm shares last traded on the BSE in May at 4.0 levs apiece. The price translates into market capitalisation of 24 million levs ($14.3 million/12.3 million euro).
On Friday, Sopharma said it has taken actions to delist Unipharm's shares from the BSE and the financial regulator's register of public companies, and to register the new shareholders with the Central Depository.
(1 euro = 1.95583 levs)